Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Wuxi Biologics (Cayman) (1FW2) vs. Competitors

5 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:1FW2Wuxi Biologics (Cayman)EUR 5.60EUR 23.20B34.3749.73%Strong BuyUnlock the DE:1FW2 analyst price target with TipRanks PremiumDE:1FW2Unlock the DE:1FW2 top-analyst price target with TipRanks Premium
HK:1548Genscript BiotechHKD 31.84HKD 78.95B-13.5985.55%Strong BuyUnlock the HK:1548 analyst price target with TipRanks PremiumDE:1FW2 vs HK:1548Unlock the HK:1548 top-analyst price target with TipRanks Premium
HK:3759Pharmaron Beijing Co., Ltd. Class HHKD 29.86HKD 86.15B44.6125.25%Strong BuyUnlock the HK:3759 analyst price target with TipRanks PremiumDE:1FW2 vs HK:3759Unlock the HK:3759 top-analyst price target with TipRanks Premium
HK:1521Frontage Holdings Corp.HKD 2.09HKD 4.27B51.1189.55%―Unlock the HK:1521 analyst price target with TipRanks PremiumDE:1FW2 vs HK:1521Unlock the HK:1521 top-analyst price target with TipRanks Premium
HK:1873Viva Biotech HoldingsHKD 1.30HKD 2.71B13.47-40.09%―Unlock the HK:1873 analyst price target with TipRanks PremiumDE:1FW2 vs HK:1873Unlock the HK:1873 top-analyst price target with TipRanks Premium
HK:2315Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class HHKD 43.82HKD 19.14B43.8644.14%―Unlock the HK:2315 analyst price target with TipRanks PremiumDE:1FW2 vs HK:2315Unlock the HK:2315 top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:1FW2Wuxi Biologics (Cayman)5.601.8850.54%
HK:1548Genscript Biotech31.8414.5584.15%
HK:3759Pharmaron Beijing Co., Ltd. Class H29.866.8229.61%
HK:1521Frontage Holdings Corp.2.081.0194.86%
HK:1873Viva Biotech Holdings1.30-0.82-38.68%
HK:2315Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H43.8211.2834.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts